Subtype-specific circadian clock dysregulation modulates breast cancer biology, invasiveness, and prognosis.
J. A. Hammarlund, S.-Y. Li, G. Wu, J.-W. Lian, S. J. Howell, R. Clarke, A. Adamson, C. F. Goncalves, J. B. Hogenesch, Q.-J. A. Meng, R. C. Anafi
This study identifies subtype-specific circadian clock dysregulation in breast cancer, linking it to EMT, invasiveness, and poorer prognosis.
bioRxiv · May 17, 2023 · PreprintCancer Biology